导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.89% | 154/354 |
| 近一周 | -1.84% | 185/356 |
| 近一月 | -3.54% | 223/362 |
| 近一季 | 1.22% | 127/362 |
| 近半年 | 8.85% | 160/358 |
| 近一年 | 8.51% | 170/349 |
| 近两年 | 16.56% | 223/314 |
| 近三年 | 34.35% | 132/244 |
| 成立以来 | 264.82% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.06% 92/360 |
8.77% 147/366 |
- - |
- - |
| 2025 | 6.48% 284/358 |
-1.70% 202/340 |
5.01% 183/348 |
3.33% 322/354 |
-0.17% 182/358 |
| 2024 | 11.65% 179/329 |
6.82% 95/280 |
-2.44% 219/310 |
6.86% 136/318 |
0.26% 143/329 |
| 2023 | 13.31% 73/275 |
1.08% 134/205 |
8.54% 68/230 |
-5.23% 162/262 |
8.99% 104/276 |
| 2022 | -3.89% 21/201 |
-3.14% 18/153 |
-9.06% 86/164 |
0.60% 27/189 |
8.46% 113/202 |
| 2021 | 22.71% 36/150 |
10.93% 24/312 |
4.31% 144/328 |
-0.18% 103/358 |
6.24% 53/151 |
| 2020 | 0.76% 54/103 |
-26.12% 235/280 |
19.16% 105/295 |
1.99% 146/299 |
12.21% 92/305 |
| 2019 | 26.94% 30/88 |
11.46% 95/258 |
5.30% 32/268 |
3.03% 70/253 |
4.99% 150/266 |
| 2018 | -4.03% 29/79 |
- - |
- - |
- - |
-13.42% 154/241 |
| 2017 | 9.04% 50/69 |
- - |
- - |
- - |
- - |
| 2016 | 18.19% 5/59 |
- - |
- - |
- - |
- - |
| 2015 | 2.35% 16/49 |
- - |
- - |
- - |
- - |
| 2014 | 11.92% 22/99 |
- - |
- - |
- - |
- - |
| 2013 | 27.26% 7/70 |
- - |
- - |
- - |
- - |
| 2012 | 13.82% 21/51 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 大成标普500等权重指数(QDII)A人民币 VS. 建信富时100指数(QDII)人民币A(539003) |